Abacus Medicine Pharma Services and AddMedica sign partnership agreement for the distribution of Siklos® in Benelux
Abacus Medicine Pharma Services (AMPS) and AddMedica are proud to announce the signing of a partnership agreement for the marketing and distribution of Siklos® in Benelux.
Abacus Medicine Pharma Services and Gen.Orph sign partnership agreement for the exclusive distribution of Miglustat Gen.Orph in Austria
Abacus Medicine Pharma Services (AMPS) and Gen.Orph are proud to announce the signing of a partnership agreement for the exclusive marketing and distribution of Miglustat Gen.Orph in Austria.
Abacus Medicine Pharma Services and Luye Pharma sign distribution agreement for Named Patient Program (NPP) of Lurbinectedin in Hong Kong
Abacus Medicine Pharma Services (AMPS) and Luye Pharma Group are proud to announce the signing of an exclusive distribution contract to make Lurbinectedin available to small cell lung cancer patients in Hong Kong via the Named Patient Program (NPP).
Aposave rebrands to Abacus Medicine Pharma Services
Abacus Medicine Pharma Services is the new name for healthcare and pharma services company previously known as Aposave.
Aposave and CTRS enter strategic partnership
The strategic partnership will drive awareness and treatment of Bile Acid Synthesis Disorders in the Benelux region.
Aposave’s Virtual Clinical Trial Congresses in 2021
What do Clinical Trials, San Antonio (Texas), COVID-19, Madrid, Aposave and Burlingame (California) have in common?
Clinical Trial Comparator challenges in 2020
Aposave writes article for the Clinical Supply Trial Handbook 2021.
Webinar: Mitigating CTS costs post-COVID
What do Clinical Trials, San Antonio (Texas), COVID-19, Madrid, Aposave and Burlingame (California) have in common?